Cargando…

Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer

Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall survival (OS). One of the key components of cachexia is anorexia; it is not known whether anorexia impacts on OS and there is no method of routine screening in current practice. Diagnosis relies on patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, Marc, Kordatou, Zoe, Barriuso, Jorge, Lamarca, Angela, Weaver, Jamie M. J., Cipriano, Claudia, Papaxoinis, George, Backen, Alison, Mansoor, Wasat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881015/ https://www.ncbi.nlm.nih.gov/pubmed/31774822 http://dx.doi.org/10.1371/journal.pone.0224540

Ejemplares similares

Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations
por: Papaxoinis, George, et al.
Publicado: (2018)

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
por: Megdanova-Chipeva, Vera G., et al.
Publicado: (2020)

Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice
por: Lamarca, Angela, et al.
Publicado: (2022)

Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Dietary Assessment (PanDA): a study protocol
por: Carnie, Lindsay E, et al.
Publicado: (2021)

The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers
por: Lamarca, Angela, et al.
Publicado: (2018)

Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment—PanDA)
por: Carnie, Lindsay E., et al.
Publicado: (2023)

Urine Telomerase for Diagnosis and Surveillance of Bladder Cancer
por: Lamarca, Angela, et al.
Publicado: (2012)

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
por: Waddell, Tom, et al.
Publicado: (2013)

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
por: Jimenez-Fonseca, Paula, et al.
Publicado: (2023)

PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours
por: Lamarca, Angela, et al.
Publicado: (2018)

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
por: Flynn, Michael, et al.
Publicado: (2018)

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes
por: Saavedra, Cristina, et al.
Publicado: (2019)

Trends and variation in the management of oesophagogastric cancer patients: a population-based survey
por: Lyratzopoulos, Georgios, et al.
Publicado: (2009)

Failure to rescue patients from early critical complications of oesophagogastric cancer surgery
por: Weledji, Elroy P., et al.
Publicado: (2016)

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
por: Shahnam, Adel, et al.
Publicado: (2023)

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
por: Bose, Katrin, et al.
Publicado: (2017)

Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification
por: Triadafilopoulos, George, et al.
Publicado: (2018)

Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction
por: Gehwolf, P., et al.
Publicado: (2020)

Laparoscopic vs. open feeding jejunostomy insertion in oesophagogastric cancer
por: Mastoridis, Sotiris, et al.
Publicado: (2021)

Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies
por: Asadi-Lari, Mohsen, et al.
Publicado: (2018)

Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
por: Baxter, Mark A, et al.
Publicado: (2023)

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
por: Cunningham, David, et al.
Publicado: (2017)

Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery
por: Moyes, LH, et al.
Publicado: (2013)

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
por: Schmidt, T, et al.
Publicado: (2014)

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer
por: Markar, Sheraz R., et al.
Publicado: (2018)

The Development, Application and Analysis of an Enhanced Recovery Programme for Major Oesophagogastric Resection
por: Underwood, Timothy J., et al.
Publicado: (2017)

The Effect of COVID-19 on Multidisciplinary Team (MDT) Outcomes for Oesophagogastric Cancer
por: Matias, Nadia, et al.
Publicado: (2023)

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction
por: Moureau-Zabotto, Laurence, et al.
Publicado: (2015)

Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection
por: Savva, K.-V., et al.
Publicado: (2021)

Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Chiramel, Jaseela, et al.
Publicado: (2017)

The role of the Shuttle Walking Test in predicting mortality and morbidity post oesophagogastric surgery
por: Whiting, P, et al.
Publicado: (2005)

Endoluminal Vacuum Therapy (E-Vac): A Treatment Option in Oesophagogastric Surgery
por: Pournaras, D. J., et al.
Publicado: (2018)

Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours
por: Lorusso, Alessandro, et al.
Publicado: (2022)

Outcomes following Oesophagogastric Resections during COVID-19: A Comparative Analysis
por: Nnaji, Martin, et al.
Publicado: (2021)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment
por: Vadhwana, Bhamini, et al.
Publicado: (2023)

Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib, et al.
Publicado: (2021)

Lower pattern recognition memory scores in anorexia nervosa
por: Keeler, Johanna, et al.
Publicado: (2021)

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer
por: Rao, S, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vpc35l9sdu7fuechea7gjme09a